{
    "2019-09-16": [
        [
            {
                "time": "",
                "original_text": "“A+H”又添一股，曾上市连获13个涨停板",
                "features": {
                    "keywords": [
                        "A+H股",
                        "新股",
                        "涨停板"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股票市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-30",
                "original_text": "2019上半年，这5家药企销售费用均超32亿元",
                "features": {
                    "keywords": [
                        "药企",
                        "销售费用",
                        "2019上半年"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "张江药谷嬗变：从稻田到“创新高地”",
                "features": {
                    "keywords": [
                        "张江药谷",
                        "创新高地",
                        "医药产业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "中概股新“造壳运动”，大佬们正闷声发大财",
                "features": {
                    "keywords": [
                        "中概股",
                        "造壳运动",
                        "投资收益"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "海外上市",
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海宏达新材料股份有限公司上海复星医药（集团）股份有限公司",
                "features": {
                    "keywords": [
                        "宏达新材料",
                        "复星医药",
                        "上市公司"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新材料",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}